Who wants to cross borders in the EU for healthcare? An analysis of the Eurobarometer data in 2007 and 2014

Peralta‐Santos, André; Perelman, Julian

doi:10.1093/eurpub/cky071

Cited by 5 publications

(4 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…When quantified in a 2009 study of 200 hospitals across 8 countries foreign patients accounted for less than 1% of hospital admissions. [9] , [13] , [30] , [32] , [45] , [48] , [49] , [50] , [51] , [52] Many citizens living abroad chose to return home for healthcare and those who travelled for care tended to be younger patients. The most commonly treated conditions were heart disease and fractures.…”

Section: Challenges To Cross-border Healthcare In Europementioning

confidence: 99%

“…The most commonly treated conditions were heart disease and fractures. [9] , [51] , [52] , [53] In a 2018 report by the European Commission, member states reported that the number of patients who travelled for care annually in 2016 and 2017 was approximately 200 000 patients. In 2016 cross border healthcare cost the EU €65 000 000.…”

Section: Challenges To Cross-border Healthcare In Europementioning

confidence: 99%

See 1 more Smart Citation

Cross-border healthcare: A review and applicability to North America during COVID-19

et al. 2022

View full text Add to dashboard Cite

Cross-border healthcare is an international agreement for the provision of out of country healthcare for citizens of partnered countries. The European Union (EU) has established itself as a world leader in cross-border healthcare. During the Coronavirus disease of 2019 (COVID-19) pandemic, the EU used this system to maximize utilization of resources. Countries with capacity accepted critically ill patients from overwhelmed nations, borders remained open to healthcare workers and those seeking medical care in an effort to share the burden of this pandemic. Significant research into the challenges and successes of cross-border healthcare was completed prior to COVID-19, which demonstrated significant benefit for patients. In North America, the response to the COVID-19 crisis has been more isolationist. The Canada-United States border has been closed and bans placed on healthcare workers crossing the border for work. Prior to COVID-19, cross-border healthcare was rare in North America despite its need. We reviewed the literature surrounding cross-border healthcare in the EU, as well as the need for a similar system in North America. We found the EU cross-border healthcare agreements are generally mutually beneficial for participating countries. The North American literature suggested a cross-border healthcare system is feasible. A number of challenges could be identified based on the EU experience. A prior agreement may have been beneficial during the COVID-19 crisis as many Canadian healthcare institutions-maintained capacity to accept critically ill patients.

show abstract

Section: Challenges To Cross-border Healthcare In Europementioning

confidence: 99%

Section: Challenges To Cross-border Healthcare In Europementioning

confidence: 99%

Cross-border healthcare: A review and applicability to North America during COVID-19

et al. 2022

View full text Add to dashboard Cite

show abstract

“…The European (2011) directive on cross-border care allows EU citizens to access health care in any EU country. Using the Eurobarometer survey, Perelta-Santos and Perelman (2018) and Riedel (2016) have found that mobility within the EU has grown from 3.3% in 2007 to 4.6% in 2014. Thus, the EU patient directive (2011) has not altered the situation much.…”

Section: Travel For Basic Health Care: the Patient Approachmentioning

confidence: 99%

Health and Wellness–Related Travel: A Scoping Study of the Literature in 2010-2018

et al. 2021

View full text Add to dashboard Cite

Health and wellness–related travel, also known as medical tourism, is a topical phenomenon with a wide range of effects in both local and transnational contexts. This scoping study examines the literature on this phenomenon from the perspective of travelers. The literature search was conducted using three databases (EBSCOhost, Web of Science, and SCOPUS) and covered the period from 2010 to 2018. The results show that the literature is divided into two academic fields: social sciences and tourism. Travel from the Global North to the Global South still dominates the field of medical travel research, and studies on South-to-South or intra-regional travel are underrepresented. There is a need for a more in-depth qualitative understanding of travelers’ lived experiences and for studies with more advanced quantitative methods and longitudinal research designs. We call for more interdisciplinary and theoretical approaches to health and wellness–related travel and propose a conceptual model that considers travelers’ intent (medical/wellness) and status (patient/tourist).

show abstract

“…This directive has had a significant impact on the demand for cross‐border health care in the EU. Peralta‐Santos and Perelman () revealed that cross‐border patient mobility among EU countries increased by approximately 11% from 2007 to 2014, particularly for younger travellers and the relatively educated, and for smaller countries.…”

Section: Introductionmentioning

confidence: 99%

Effect of Cross‐border Health Care on Quality and Progressivity of Financing

Aiura

2019

Rev Urban & Reg Develop

View full text Add to dashboard Cite

In this study, we examine the effect of cross‐border health care in terms of public health insurance. We consider its effect on healthcare quality and progressivity of financing. We use a two‐country Hotelling model in which consumers are divided into two groups: high and low innate‐talent consumers. Aiming to maximize social welfare, governments impose a progressive income tax on consumers to provide healthcare services. Assuming that a payment scheme for healthcare services is based on diagnosis‐related group pricing, which has been adapted in many countries, we obtain the following results. The promotion of cross‐border health care does not influence healthcare quality or the progressivity of financing in patient‐importing countries, but does reduce healthcare quality and influence the progressivity of financing in patient‐exporting countries.

show abstract

Who wants to cross borders in the EU for healthcare? An analysis of the Eurobarometer data in 2007 and 2014

Abstract: Cross-border patient mobility is more likely amongst the younger, the more educated and those from smaller countries. The directive does not seem to have promoted mobility at a large scale among the neediest citizens.

Cited by 5 publications

References 22 publications

Cross-border healthcare: A review and applicability to North America during COVID-19

Cross-border healthcare: A review and applicability to North America during COVID-19

Health and Wellness–Related Travel: A Scoping Study of the Literature in 2010-2018

Effect of Cross‐border Health Care on Quality and Progressivity of Financing

Contact Info

Product

Resources

About